
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
A. 510(k) Number:
k100607
B. Purpose for Submission:
Addition of a new parameter - RDW-SD (Red Cell Distribution Width-Standard
Deviation) to the COULTER® 4C®-EX 300 Cell Control.
C. Measurand:
WBC, RBC, Hgb, Hct, MCV, MCH, MCHC, RDW, RDW-SD, Plt, MPV and [LY
(%/#), MO (%/#), GR (%/#)].
D. Type of Test:
Quantitative
E. Applicant:
Beckman Coulter, Inc.
F. Proprietary and Established Names:
COULTER® 4C®-EX 300 Cell Control
G. Regulatory Information:
1. Regulation section:
21 CFR § 864.8625, Hematology quality control mixture
2. Classification:
Class II
3. Product code:
JPK, Mixture, hematology quality control
4. Panel:
Hematology (81)
H. Intended Use:
1. Intended use(s):
4C®-EX 300 Cell Control is a hematology quality control material used to
monitor the performance of COULTER® hematology analyzers listed in the
TABLE OF EXPECTED RESULTS in conjunction with specific COULTER
reagents (Refer to your instrument specific instructions for use).
The assigned values and expected ranges on the TABLE OF EXPECTED
RESULTS can be used to monitor instrument performance. This product can also
be used to establish your own laboratory mean.
2. Indication(s) for use:
Same as Intended Use
3. Special conditions for use statement(s):
Not applicable
4. Special instrument requirements:
For use on Coulter DxH™ 300 and DxH™ 300C analyzers
I. Device Description:
4C®-EX 300 Cell Control is a hematology quality control mixture intended to be
used with automated cell and differential cell counters. It is prepared from stabilized
human blood so that repeated measurements by an automated cell or differential cell
counter can be made to monitor instrument daily performance. 4C®-EX 300 Cell
1

--- Page 2 ---
Control consists of treated, stabilized human erythrocytes, a stabilized platelet sized
component, and fixed erythrocytes that simulate leukocytes. Three levels of varying
component concentrations (Abnormal Low, Abnormal High, and Normal) are offered.
J. Substantial Equivalence Information:
1. Predicate device name(s):
COULTER® 4C®-ES Cell Control
2. Predicate 510(k) number(s):
k010064
3. Comparison with predicate:
Similarities
Item 4C®-EX 300 Cell Control 4C®-ES Cell Control
Product Consists of treated, stabilized human erythrocytes in an Same
Description isotonic medium. It also contains a stabilized platelet-
sized component, and fixed erythrocytes to simulate
leukocytes.
Intended Use A hematology quality control material used to monitor Same
the performance of Beckman Coulter instruments listed
in the Table of Expected Results in conjunction with
specific Coulter reagents (Refer to your instrument
specific instructions for use). The assigned values and
expected ranges on the Table of Expected Results can
be used to monitor instrument performance. This
product can also be used to establish your own
laboratory mean.
Cellular White blood cells (Leukocytes), Red blood cells Same
Populations (Erythrocytes), Platelets, Lymphocytes, Monocytes,
and Granulocytes
Assayed WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, Same except RDW-SD
Parameters RDW-SD, PLT, MPV, LY%, MO%, GR%, LY#,
MO#, GR#.
Final Product Three levels. Liquid, ready to use reagent. Same
Form
Open Vial 20 events over 35 days when stored at 2 - 8°C. Same
Stability
Differences
Item 4C®-EX 300 Cell Control 4C®-ES Cell Control
Closed Vial 145 days when stored at 2 - 8°C 154 days when stored at 2 -
Stability 8°C.
Analyzers DxH™ 300 COULTER® Cellular Analysis ONYX™, ONYX™ with
System/DxH™ 300C COULTER® Cellular Analysis Autoloader, MD™ Series,
System capable of analyzing the RDW-SD parameter. MD™ II, Ac•T ™ 8/10, Ac•T
diff™, Ac•T diff2™, JT™,
JT2, JT3 and T Series.
K. Standard/Guidance Document Referenced (if applicable):
CLSI EP05-A2, Evaluation of Precision Performance of Quantitative Measurement
Methods; Approved Guideline-Second Edition
CLSI EP25-A, Evaluation of Stability of In Vitro Diagnostic Reagents; Approved
Guideline
2

[Table 1 on page 2]
Similarities								
	Item			4C®-EX 300 Cell Control			4C®-ES Cell Control	
Product
Description			Consists of treated, stabilized human erythrocytes in an
isotonic medium. It also contains a stabilized platelet-
sized component, and fixed erythrocytes to simulate
leukocytes.			Same		
Intended Use			A hematology quality control material used to monitor
the performance of Beckman Coulter instruments listed
in the Table of Expected Results in conjunction with
specific Coulter reagents (Refer to your instrument
specific instructions for use). The assigned values and
expected ranges on the Table of Expected Results can
be used to monitor instrument performance. This
product can also be used to establish your own
laboratory mean.			Same		
Cellular
Populations			White blood cells (Leukocytes), Red blood cells
(Erythrocytes), Platelets, Lymphocytes, Monocytes,
and Granulocytes			Same		
Assayed
Parameters			WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW,
RDW-SD, PLT, MPV, LY%, MO%, GR%, LY#,
MO#, GR#.			Same except RDW-SD		
Final Product
Form			Three levels. Liquid, ready to use reagent.			Same		
Open Vial
Stability			20 events over 35 days when stored at 2 - 8°C.			Same		

[Table 2 on page 2]
Differences								
	Item			4C®-EX 300 Cell Control			4C®-ES Cell Control	
Closed Vial
Stability			145 days when stored at 2 - 8°C			154 days when stored at 2 -
8°C.		
Analyzers			DxH™ 300 COULTER® Cellular Analysis
System/DxH™ 300C COULTER® Cellular Analysis
System capable of analyzing the RDW-SD parameter.			ONYX™, ONYX™ with
Autoloader, MD™ Series,
MD™ II, Ac•T ™ 8/10, Ac•T
diff™, Ac•T diff2™, JT™,
JT2, JT3 and T Series.		

--- Page 3 ---
L. Test Principle:
COULTER® 4C®- EX 300 Cell Control is a reference product prepared from
stabilized human blood cells. 4C®- EX 300 Cell Control confirms and monitors
instrument accuracy and precision performance by providing measurements for
counting, sizing and hemoglobin determination.
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
Two separate studies demonstrate the precision/reproducibility of the DxH
300/300C systems.
Study 1: One lot of each level of 4C-EX 300 Cell Control (Abnormal Low,
Normal and Abnormal High) was run in duplicate twice each day for a minimum
of 20 days on the DxH 300 and DxH 300C analyzers at three test sites. The
results were analyzed according to the guidance provided in CLSI EP05-A2.
Variance components were estimated for all sources of variability controlled in
the experiment based on a nested structure (site, day-within site, within day, and
repeatability). Negative values of variance component estimates were defaulted
to zero. The individual results are compared against the
repeatability/reproducibility specifications. The results met the acceptance
criteria as displayed in the tables below.
4C-EX 300 Cell Control Precision Abnormal Low Level
DxH 300C
Parameter Mean CV%
Within Reproducibility Repeatability
Site/Instrument Day Repeatability
Day Specification Specification
WBC 3.8 2.1 1.0 0.8 8.0 2.0 5.0
RBC 2.47 3.5 0.5 1.1 6.2 0.9 4.0
HGB 6.8 1.0 0.7 0.7 6.4 0.7 1.5
HCT 19.5 4.7 0.0 1.3 N/A 0.9 N/A
MCV 79.1 1.2 0.1 0.3 3.4 0.2 1.0
MCH 27.6 2.7 0.0 0.7 N/A 0.8 N/A
MCHC 34.8 3.9 0.0 0.7 N/A 0.8 N/A
RDW 13.7 1.0 1.1 0.9 12.4 1.6 3.5
RDW-SD 40.7 1.7 0.9 0.8 13.7 1.4 3.5
PLT 78 3.6 3.0 1.1 18.8 4.4 15.0
MPV 9.9 2.6 1.1 0.0 9.4 2.4 3.0
LY% 34.2 1.1 1.0 1.1 12.0 3.3 4.4
MO% 12.5 1.0 2.3 2.6 21.4 5.6 24.1
GR% 53.3 0.5 0.0 0.6 6.8 1.9 5.6
LY# 1.3 1.2 1.6 0.8 N/A 4.4 N/A
MO# 0.5 3.3 3.5 0.0 N/A 8.5 N/A
GR# 2.0 2.2 0.8 0.6 N/A 3.8 N/A
3

[Table 1 on page 3]
DxH 300C							
Parameter	Mean	CV%					
		Site/Instrument	Day	Within
Day	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	3.8	2.1	1.0	0.8	8.0	2.0	5.0
RBC	2.47	3.5	0.5	1.1	6.2	0.9	4.0
HGB	6.8	1.0	0.7	0.7	6.4	0.7	1.5
HCT	19.5	4.7	0.0	1.3	N/A	0.9	N/A
MCV	79.1	1.2	0.1	0.3	3.4	0.2	1.0
MCH	27.6	2.7	0.0	0.7	N/A	0.8	N/A
MCHC	34.8	3.9	0.0	0.7	N/A	0.8	N/A
RDW	13.7	1.0	1.1	0.9	12.4	1.6	3.5
RDW-SD	40.7	1.7	0.9	0.8	13.7	1.4	3.5
PLT	78	3.6	3.0	1.1	18.8	4.4	15.0
MPV	9.9	2.6	1.1	0.0	9.4	2.4	3.0
LY%	34.2	1.1	1.0	1.1	12.0	3.3	4.4
MO%	12.5	1.0	2.3	2.6	21.4	5.6	24.1
GR%	53.3	0.5	0.0	0.6	6.8	1.9	5.6
LY#	1.3	1.2	1.6	0.8	N/A	4.4	N/A
MO#	0.5	3.3	3.5	0.0	N/A	8.5	N/A
GR#	2.0	2.2	0.8	0.6	N/A	3.8	N/A

--- Page 4 ---
DxH 300
Parameter Mean CV%
Within Reproducibility Repeatability
Site/Instrument Day Repeatability
Day Specification Specification
WBC 3.8 2.4 1.4 0.0 8.0 2.2 5.0
RBC 2.49 2.5 0.7 0.9 6.2 0.8 4.0
HGB 6.8 1.3 0.8 0.4 6.4 0.8 1.5
HCT 19.7 2.9 0.3 1.0 N/A 0.9 N/A
MCV 79.1 0.8 0.1 0.3 3.4 0.2 1.0
MCH 27.2 3.2 0.0 0.6 N/A 0.7 N/A
MCHC 34.4 3.8 0.0 0.8 N/A 0.8 N/A
RDW 13.7 1.1 0.5 1.1 12.4 1.7 3.5
RDW-SD 40.3 0.9 0.0 0.9 13.7 1.6 3.5
PLT 80 3.2 5.6 1.8 18.8 4.1 15.0
MPV 9.9 1.9 0.0 0.0 9.4 2.8 3.0
LY% 34.5 0.4 0.0 1.6 12.0 3.3 4.4
MO% 12.4 0.0 2.1 0.5 21.4 5.8 24.1
GR% 53.2 0.2 0.3 0.7 6.8 1.8 5.6
LY# 1.3 2.4 1.3 1.7 N/A 4.4 N/A
MO# 0.5 2.9 2.5 0.0 N/A 9.2 N/A
GR# 2.0 2.2 1.3 0.0 N/A 3.7 N/A
4C-EX 300 Cell Control Precision Normal Level
DxH 300C
Parameter Mean CV%
Within Reproducibility Repeatability
Site/Instrument Day Repeatability
Day Specification Specification
WBC 8.7 2.4 0.6 0.9 4.9 1.4 3.0
RBC 4.17 3.0 0.0 1.3 3.6 0.6 2.0
HGB 12.9 0.3 0.8 0.8 4.3 0.8 1.5
HCT 36.8 4.2 0.0 1.5 N/A 0.2 N/A
MCV 88.2 1.2 0.0 0.4 3.1 0.1 1.0
MCH 31.0 2.8 0.0 0.8 N/A 0.5 N/A
MCHC 35.2 4.0 0.0 1.1 N/A 0.0 N/A
RDW 12.0 0.6 0.1 0.5 12.7 1.1 3.5
RDW-SD 41.6 1.3 0.5 0.3 13.6 1.3 3.5
PLT 224 3.8 2.2 0.0 15.4 2.5 5.0
MPV 10.3 2.6 0.9 0.0 12.6 1.1 3.0
LY% 45.8 0.7 0.7 0.0 6.6 1.8 3.3
MO% 12.8 1.5 1.3 0.0 18.1 4.0 23.4
GR% 41.5 0.7 0.6 0.0 9.0 1.6 7.2
LY# 4.0 1.9 1.3 1.0 N/A 2.6 N/A
4

[Table 1 on page 4]
DxH 300							
Parameter	Mean	CV%					
		Site/Instrument	Day	Within
Day	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	3.8	2.4	1.4	0.0	8.0	2.2	5.0
RBC	2.49	2.5	0.7	0.9	6.2	0.8	4.0
HGB	6.8	1.3	0.8	0.4	6.4	0.8	1.5
HCT	19.7	2.9	0.3	1.0	N/A	0.9	N/A
MCV	79.1	0.8	0.1	0.3	3.4	0.2	1.0
MCH	27.2	3.2	0.0	0.6	N/A	0.7	N/A
MCHC	34.4	3.8	0.0	0.8	N/A	0.8	N/A
RDW	13.7	1.1	0.5	1.1	12.4	1.7	3.5
RDW-SD	40.3	0.9	0.0	0.9	13.7	1.6	3.5
PLT	80	3.2	5.6	1.8	18.8	4.1	15.0
MPV	9.9	1.9	0.0	0.0	9.4	2.8	3.0
LY%	34.5	0.4	0.0	1.6	12.0	3.3	4.4
MO%	12.4	0.0	2.1	0.5	21.4	5.8	24.1
GR%	53.2	0.2	0.3	0.7	6.8	1.8	5.6
LY#	1.3	2.4	1.3	1.7	N/A	4.4	N/A
MO#	0.5	2.9	2.5	0.0	N/A	9.2	N/A
GR#	2.0	2.2	1.3	0.0	N/A	3.7	N/A

[Table 2 on page 4]
DxH 300C							
Parameter	Mean	CV%					
		Site/Instrument	Day	Within
Day	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	8.7	2.4	0.6	0.9	4.9	1.4	3.0
RBC	4.17	3.0	0.0	1.3	3.6	0.6	2.0
HGB	12.9	0.3	0.8	0.8	4.3	0.8	1.5
HCT	36.8	4.2	0.0	1.5	N/A	0.2	N/A
MCV	88.2	1.2	0.0	0.4	3.1	0.1	1.0
MCH	31.0	2.8	0.0	0.8	N/A	0.5	N/A
MCHC	35.2	4.0	0.0	1.1	N/A	0.0	N/A
RDW	12.0	0.6	0.1	0.5	12.7	1.1	3.5
RDW-SD	41.6	1.3	0.5	0.3	13.6	1.3	3.5
PLT	224	3.8	2.2	0.0	15.4	2.5	5.0
MPV	10.3	2.6	0.9	0.0	12.6	1.1	3.0
LY%	45.8	0.7	0.7	0.0	6.6	1.8	3.3
MO%	12.8	1.5	1.3	0.0	18.1	4.0	23.4
GR%	41.5	0.7	0.6	0.0	9.0	1.6	7.2
LY#	4.0	1.9	1.3	1.0	N/A	2.6	N/A

--- Page 5 ---
MO# 1.1 2.5 0.6 0.0 N/A 5.4 N/A
GR# 3.6 3.0 1.1 0.0 N/A 2.4 N/A
DxH 300
Parameter Mean CV%
Within Reproducibility Repeatability
Site/Instrument Day Repeatability
Day Specification Specification
WBC 8.7 2.3 1.0 0.3 4.9 1.4 3.0
RBC 4.19 2.1 0.8 0.6 3.6 0.8 2.0
HGB 12.9 1.3 0.7 0.4 4.3 0.6 1.5
HCT 37.0 2.6 0.6 0.8 N/A 0.8 N/A
MCV 88.3 0.8 0.0 0.3 3.1 0.1 1.0
MCH 30.5 3.0 0.0 0.6 N/A 0.8 N/A
MCHC 34.9 3.6 0.0 0.8 N/A 0.7 N/A
RDW 12.0 0.8 0.5 0.0 12.7 1.0 3.5
RDW-SD 41.4 1.2 0.4 0.0 13.6 1.2 3.5
PLT 227 2.9 3.0 0.4 15.4 2.9 5.0
MPV 10.3 2.0 0.9 0.4 12.6 1.0 3.0
LY% 45.9 0.3 0.7 0.5 6.6 1.7 3.3
MO% 12.8 0.1 1.8 0.0 18.1 4.4 23.4
GR% 41.3 0.3 0.5 0.8 9.0 1.4 7.2
LY# 4.0 2.5 1.2 0.1 N/A 2.4 N/A
MO# 1.1 1.6 1.3 0.0 N/A 5.3 N/A
GR# 3.6 2.3 1.3 1.1 N/A 2.1 N/A
4C-EX 300 Cell Control Precision Abnormal High Level
DxH 300C
Parameter Mean CV%
Within Reproducibility Repeatability
Site/Instrument Day Repeatability
Day Specification Specification
WBC 18.0 2.3 0.9 0.9 4.0 0.9 3.0
RBC 5.34 2.8 0.7 0.8 3.4 0.8 2.0
HGB 18.3 0.7 0.7 0.8 3.1 0.5 1.5
HCT 51.6 4.1 0.5 0.9 N/A 0.7 N/A
MCV 96.7 1.3 0.0 0.3 3.1 0.0 1.0
MCH 34.3 2.3 0.0 0.4 N/A 0.7 N/A
MCHC 35.5 3.6 0.0 0.4 N/A 0.6 N/A
RDW 11.6 0.5 0.4 0.5 13.2 0.8 3.5
RDW-SD 44.2 1.5 0.6 0.6 14.3 1.2 3.5
PLT 436 4.5 1.5 1.3 11.4 1.5 5.0
MPV 10.3 2.8 0.8 0.0 12.4 0.7 3.0
LY% 50.5 0.7 0.4 0.3 6.1 1.1 5.9
MO% 15.7 1.4 0.7 0.5 18.3 2.6 19.1
5

[Table 1 on page 5]
MO#	1.1	2.5	0.6	0.0	N/A	5.4	N/A
GR#	3.6	3.0	1.1	0.0	N/A	2.4	N/A
DxH 300							
Parameter	Mean	CV%					
		Site/Instrument	Day	Within
Day	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	8.7	2.3	1.0	0.3	4.9	1.4	3.0
RBC	4.19	2.1	0.8	0.6	3.6	0.8	2.0
HGB	12.9	1.3	0.7	0.4	4.3	0.6	1.5
HCT	37.0	2.6	0.6	0.8	N/A	0.8	N/A
MCV	88.3	0.8	0.0	0.3	3.1	0.1	1.0
MCH	30.5	3.0	0.0	0.6	N/A	0.8	N/A
MCHC	34.9	3.6	0.0	0.8	N/A	0.7	N/A
RDW	12.0	0.8	0.5	0.0	12.7	1.0	3.5
RDW-SD	41.4	1.2	0.4	0.0	13.6	1.2	3.5
PLT	227	2.9	3.0	0.4	15.4	2.9	5.0
MPV	10.3	2.0	0.9	0.4	12.6	1.0	3.0
LY%	45.9	0.3	0.7	0.5	6.6	1.7	3.3
MO%	12.8	0.1	1.8	0.0	18.1	4.4	23.4
GR%	41.3	0.3	0.5	0.8	9.0	1.4	7.2
LY#	4.0	2.5	1.2	0.1	N/A	2.4	N/A
MO#	1.1	1.6	1.3	0.0	N/A	5.3	N/A
GR#	3.6	2.3	1.3	1.1	N/A	2.1	N/A

[Table 2 on page 5]
DxH 300C							
Parameter	Mean	CV%					
		Site/Instrument	Day	Within
Day	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	18.0	2.3	0.9	0.9	4.0	0.9	3.0
RBC	5.34	2.8	0.7	0.8	3.4	0.8	2.0
HGB	18.3	0.7	0.7	0.8	3.1	0.5	1.5
HCT	51.6	4.1	0.5	0.9	N/A	0.7	N/A
MCV	96.7	1.3	0.0	0.3	3.1	0.0	1.0
MCH	34.3	2.3	0.0	0.4	N/A	0.7	N/A
MCHC	35.5	3.6	0.0	0.4	N/A	0.6	N/A
RDW	11.6	0.5	0.4	0.5	13.2	0.8	3.5
RDW-SD	44.2	1.5	0.6	0.6	14.3	1.2	3.5
PLT	436	4.5	1.5	1.3	11.4	1.5	5.0
MPV	10.3	2.8	0.8	0.0	12.4	0.7	3.0
LY%	50.5	0.7	0.4	0.3	6.1	1.1	5.9
MO%	15.7	1.4	0.7	0.5	18.3	2.6	19.1

--- Page 6 ---
GR% 33.8 0.7 0.2 0.0 9.1 1.3 8.9
LY# 9.1 2.1 1.0 0.7 N/A 1.6 N/A
MO# 2.8 2.3 1.2 0.8 N/A 2.6 N/A
GR# 6.1 2.9 0.8 1.2 N/A 1.6 N/A
DxH 300
Parameter Mean CV%
Within Reproducibility Repeatability
Site/Instrument Day Repeatability
Day Specification Specification
WBC 18.0 2.4 0.8 0.7 4.0 0.8 3.0
RBC 5.34 1.9 0.8 0.8 3.4 0.8 2.0
HGB 18.2 1.5 0.6 0.5 3.1 0.5 1.5
HCT 51.6 2.4 0.8 0.8 N/A 0.7 N/A
MCV 96.7 0.8 0.1 0.2 3.1 0.2 1.0
MCH 34.0 3.1 0.0 1.2 N/A 0.7 N/A
MCHC 35.2 3.7 0.0 0.6 N/A 0.6 N/A
RDW 11.7 0.0 0.7 0.0 13.2 0.9 3.5
RDW-SD 44.0 0.6 0.8 0.0 14.3 1.3 3.5
PLT 443 2.9 2.8 1.4 11.4 1.8 5.0
MPV 10.3 2.2 1.0 0.4 12.4 0.7 3.0
LY% 50.6 0.5 0.5 0.5 6.1 1.0 5.9
MO% 15.7 1.1 1.3 0.0 18.3 2.3 19.1
GR% 33.7 0.3 0.2 0.5 9.1 1.2 8.9
LY# 9.1 2.5 0.7 0.8 N/A 1.5 N/A
MO# 2.8 2.4 1.4 0.9 N/A 2.5 N/A
GR# 6.1 2.5 1.0 1.0 N/A 1.6 N/A
Study 2: An analysis of a subset of the 4C-EX 300 Cell Control stability data was
performed to assess the precision/reproducibility of multiple lots of the product
over time. The data was collected, and included three lots of each level of 4C-EX
Cell Control (Abnormal Low, Normal and Abnormal High). For each lot, five
replicates per day for a total of four days were obtained on one DxH 300 and one
DxH 300C analyzers. The analysis of all the lots spanned throughout
approximately 45 days. All sources of variability were considered to be random.
The estimates with negative values were defaulted to zero. The individual results
are compared against the repeatability/reproducibility specifications. The results
met the acceptance criteria as displayed in the tables below.
4C-EX 300 Cell Control DxH 300/300C Precision Abnormal Low Level
Parameter Mean CV%
Reproducibility Repeatability
Day Instrument Lot Repeatability
Specification Specification
WBC 3.7 1.6 2.5 3.1 8.0 2.3 5.0
RBC 2.46 0.0 2.3 3.4 6.2 1.2 4.0
HGB 6.6 0.0 1.4 3.4 6.4 0.7 1.5
6

[Table 1 on page 6]
GR%	33.8	0.7	0.2	0.0	9.1	1.3	8.9
LY#	9.1	2.1	1.0	0.7	N/A	1.6	N/A
MO#	2.8	2.3	1.2	0.8	N/A	2.6	N/A
GR#	6.1	2.9	0.8	1.2	N/A	1.6	N/A
DxH 300							
Parameter	Mean	CV%					
		Site/Instrument	Day	Within
Day	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	18.0	2.4	0.8	0.7	4.0	0.8	3.0
RBC	5.34	1.9	0.8	0.8	3.4	0.8	2.0
HGB	18.2	1.5	0.6	0.5	3.1	0.5	1.5
HCT	51.6	2.4	0.8	0.8	N/A	0.7	N/A
MCV	96.7	0.8	0.1	0.2	3.1	0.2	1.0
MCH	34.0	3.1	0.0	1.2	N/A	0.7	N/A
MCHC	35.2	3.7	0.0	0.6	N/A	0.6	N/A
RDW	11.7	0.0	0.7	0.0	13.2	0.9	3.5
RDW-SD	44.0	0.6	0.8	0.0	14.3	1.3	3.5
PLT	443	2.9	2.8	1.4	11.4	1.8	5.0
MPV	10.3	2.2	1.0	0.4	12.4	0.7	3.0
LY%	50.6	0.5	0.5	0.5	6.1	1.0	5.9
MO%	15.7	1.1	1.3	0.0	18.3	2.3	19.1
GR%	33.7	0.3	0.2	0.5	9.1	1.2	8.9
LY#	9.1	2.5	0.7	0.8	N/A	1.5	N/A
MO#	2.8	2.4	1.4	0.9	N/A	2.5	N/A
GR#	6.1	2.5	1.0	1.0	N/A	1.6	N/A

[Table 2 on page 6]
Parameter	Mean	CV%					
		Day	Instrument	Lot	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	3.7	1.6	2.5	3.1	8.0	2.3	5.0
RBC	2.46	0.0	2.3	3.4	6.2	1.2	4.0
HGB	6.6	0.0	1.4	3.4	6.4	0.7	1.5

--- Page 7 ---
HCT 19.6 0.0 2.7 4.4 N/A 1.3 N/A
MCV 79.9 0.0 0.4 1.1 3.4 0.2 1.0
MCH 26.9 0.0 1.1 0.5 N/A 1.1 N/A
MCHC 33.6 0.0 1.4 1.2 N/A 1.1 N/A
RDW 12.3 2.0 1.3 1.8 12.4 1.4 3.5
RDW-SD 37.1 1.4 1.5 2.4 13.7 1.4 3.5
PLT 72.6 0.0 3.7 2.4 18.8 3.3 15.0
MPV 10.0 1.4 0.8 1.8 9.4 2.2 3.0
LY% 35.2 0.7 1.1 1.2 12.0 3.5 4.3
MO% 11.6 6.2 0.8 6.9 21.4 5.3 25.9
GR% 53.2 2.3 0.7 2.0 6.8 2.3 5.6
LY# 1.3 3.2 2.9 3.5 N/A 3.8 N/A
MO# 0.4 8.2 1.5 9.6 N/A 5.6 N/A
GR# 2.0 0.0 2.7 2.3 N/A 3.7 N/A
4C-EX 300 Cell Control DxH 300/300C Precision Normal Level
Parameter Mean CV%
Reproducibility Repeatability
Day Instrument Lot Repeatability
Specification Specification
WBC 8.5 0.0 3.3 2.0 4.9 1.1 3.0
RBC 4.20 0.0 2.1 0.6 3.6 1.1 2.0
HGB 12.6 0.0 1.1 0.5 4.3 0.6 1.5
HCT 37.1 0.0 2.4 0.7 N/A 1.1 N/A
MCV 88.4 0.0 0.5 0.8 3.1 0.2 1.0
MCH 29.9 0.0 1.1 0.7 N/A 1.0 N/A
MCHC 33.9 0.0 1.4 1.1 N/A 1.0 N/A
RDW 12.0 0.0 0.8 1.2 12.7 1.2 3.5
RDW-SD 40.4 0.0 1.6 1.8 13.6 1.5 3.5
PLT 217.7 0.0 3.0 1.2 15.4 2.4 5.0
MPV 10.0 1.1 0.4 0.8 12.6 0.8 3.0
LY% 45.6 0.0 0.7 0.6 6.6 1.7 3.3
MO% 13.7 1.7 2.5 3.2 18.1 3.6 21.9
GR% 40.7 0.9 0.6 1.5 9.0 1.6 7.4
LY# 3.9 0.0 3.9 2.5 N/A 1.7 N/A
MO# 1.2 3.8 0.0 4.9 N/A 4.1 N/A
GR# 3.5 0.0 3.7 0.4 N/A 2.0 N/A
4C-EX 300 Cell Control DxH 300/300C Precision Abnormal High Level
Parameter Mean CV%
Reproducibility Repeatability
Day Instrument Lot Repeatability
Specification Specification
WBC 18.2 0.0 3.6 1.9 4.0 1.0 3.0
7

[Table 1 on page 7]
HCT	19.6	0.0	2.7	4.4	N/A	1.3	N/A
MCV	79.9	0.0	0.4	1.1	3.4	0.2	1.0
MCH	26.9	0.0	1.1	0.5	N/A	1.1	N/A
MCHC	33.6	0.0	1.4	1.2	N/A	1.1	N/A
RDW	12.3	2.0	1.3	1.8	12.4	1.4	3.5
RDW-SD	37.1	1.4	1.5	2.4	13.7	1.4	3.5
PLT	72.6	0.0	3.7	2.4	18.8	3.3	15.0
MPV	10.0	1.4	0.8	1.8	9.4	2.2	3.0
LY%	35.2	0.7	1.1	1.2	12.0	3.5	4.3
MO%	11.6	6.2	0.8	6.9	21.4	5.3	25.9
GR%	53.2	2.3	0.7	2.0	6.8	2.3	5.6
LY#	1.3	3.2	2.9	3.5	N/A	3.8	N/A
MO#	0.4	8.2	1.5	9.6	N/A	5.6	N/A
GR#	2.0	0.0	2.7	2.3	N/A	3.7	N/A

[Table 2 on page 7]
Parameter	Mean	CV%					
		Day	Instrument	Lot	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	8.5	0.0	3.3	2.0	4.9	1.1	3.0
RBC	4.20	0.0	2.1	0.6	3.6	1.1	2.0
HGB	12.6	0.0	1.1	0.5	4.3	0.6	1.5
HCT	37.1	0.0	2.4	0.7	N/A	1.1	N/A
MCV	88.4	0.0	0.5	0.8	3.1	0.2	1.0
MCH	29.9	0.0	1.1	0.7	N/A	1.0	N/A
MCHC	33.9	0.0	1.4	1.1	N/A	1.0	N/A
RDW	12.0	0.0	0.8	1.2	12.7	1.2	3.5
RDW-SD	40.4	0.0	1.6	1.8	13.6	1.5	3.5
PLT	217.7	0.0	3.0	1.2	15.4	2.4	5.0
MPV	10.0	1.1	0.4	0.8	12.6	0.8	3.0
LY%	45.6	0.0	0.7	0.6	6.6	1.7	3.3
MO%	13.7	1.7	2.5	3.2	18.1	3.6	21.9
GR%	40.7	0.9	0.6	1.5	9.0	1.6	7.4
LY#	3.9	0.0	3.9	2.5	N/A	1.7	N/A
MO#	1.2	3.8	0.0	4.9	N/A	4.1	N/A
GR#	3.5	0.0	3.7	0.4	N/A	2.0	N/A

[Table 3 on page 7]
Parameter	Mean	CV%					
		Day	Instrument	Lot	Reproducibility
Specification	Repeatability	Repeatability
Specification
WBC	18.2	0.0	3.6	1.9	4.0	1.0	3.0

--- Page 8 ---
RBC 5.34 0.0 1.7 0.7 3.4 1.1 2.0
HGB 17.7 0.0 0.9 0.5 3.1 0.5 1.5
HCT 51.8 0.0 2.1 1.3 N/A 1.0 N/A
MCV 97.0 0.0 0.5 0.7 3.1 0.2 1.0
MCH 33.2 0.0 1.1 0.6 N/A 0.9 N/A
MCHC 34.2 0.0 1.4 1.3 N/A 0.9 N/A
RDW 11.6 0.5 0.3 0.6 13.2 0.8 3.5
RDW-SD 42.9 0.0 2.0 1.4 14.3 1.1 3.5
PLT 436.9 0.0 3.4 1.3 11.4 1.9 5.0
MPV 10.2 2.6 0.3 2.1 12.4 0.7 3.0
LY% 49.7 0.0 0.1 0.3 6.1 1.0 6.0
MO% 16.7 0.6 1.2 1.0 18.3 2.3 18.0
GR% 33.7 0.6 0.0 0.6 9.1 1.1 8.9
LY# 9.0 0.0 3.8 1.8 N/A 1.5 N/A
MO# 3.0 2.4 2.2 2.8 N/A 2.3 N/A
GR# 6.1 0.0 3.7 1.7 N/A 1.5 N/A
b. Linearity/assay reportable range:
Not applicable.
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Value assignment: 4C®- EX 300 Cell Control assigned values are determined
on validated systems using specific Beckman Coulter reagents. One hundred
(100) vials from each lot are taken randomly throughout the production run.
For the value assignment process, two assay runs are required on two separate
instruments. Four to seven sample vials are analyzed for each assay run. An
assay computer system is used to determine the number of replicates required
for each assay run and analyze the data in real-time. Zero biased,
equilibration adjusted data and the raw data from the instrument assay run
data is used to determine the final value assignment. The value assignments
are confirmed by performing a verification test of the product on the
instruments for which the cell control is intended to be used.
Open and Closed Vial Stability: Three lots of each level (Abnormal Low,
Normal, and Abnormal High) were processed on both DxH™ 300 and DxH™
300C analyzers. Testing was conducted throughout the proposed shelf life.
Open Vial Stability was determined to be 20 events over 35 days when stored
at 2 - 8°C. Closed Vial Stability was determined to be 145 days when stored at
2 - 8°C. The RDW-SD recovered values were compared to assay values
established at the beginning of the test interval and the expected ranges to
assess the product’s stability.
d. Detection limit:
Not applicable
e. Analytical specificity:
Not applicable
f. Assay cut-off:
8

[Table 1 on page 8]
RBC	5.34	0.0	1.7	0.7	3.4	1.1	2.0
HGB	17.7	0.0	0.9	0.5	3.1	0.5	1.5
HCT	51.8	0.0	2.1	1.3	N/A	1.0	N/A
MCV	97.0	0.0	0.5	0.7	3.1	0.2	1.0
MCH	33.2	0.0	1.1	0.6	N/A	0.9	N/A
MCHC	34.2	0.0	1.4	1.3	N/A	0.9	N/A
RDW	11.6	0.5	0.3	0.6	13.2	0.8	3.5
RDW-SD	42.9	0.0	2.0	1.4	14.3	1.1	3.5
PLT	436.9	0.0	3.4	1.3	11.4	1.9	5.0
MPV	10.2	2.6	0.3	2.1	12.4	0.7	3.0
LY%	49.7	0.0	0.1	0.3	6.1	1.0	6.0
MO%	16.7	0.6	1.2	1.0	18.3	2.3	18.0
GR%	33.7	0.6	0.0	0.6	9.1	1.1	8.9
LY#	9.0	0.0	3.8	1.8	N/A	1.5	N/A
MO#	3.0	2.4	2.2	2.8	N/A	2.3	N/A
GR#	6.1	0.0	3.7	1.7	N/A	1.5	N/A

--- Page 9 ---
Not applicable
2. Comparison studies:
a. Method comparison with predicate device:
Not applicable
b. Matrix comparison:
Not applicable
3. Clinical studies:
a. Clinical Sensitivity:
Not applicable
b. Clinical specificity:
Not applicable
c. Other clinical supportive data (when a. and b. are not applicable):
Not applicable
4. Clinical cut-off:
Not applicable
5. Expected values/Reference range:
The expected ranges for RDW-SD were calculated based upon the assigned
values and expected ranges of MCV and RDW parameters, and the mathematical
relationship between these parameters for each level of 4C®- EX 300 Cell
Controls. This methodology allows for the preservation of the same variability
built in the MCV and RDW specifications. The expected ranges are provided in
the Table of Expected Results.
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
9